<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20100701004281N4</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-11-11</date_registration>
      <primary_sponsor>Shahroud University of Medical Sciences</primary_sponsor>
      <public_title>The effect of an electronic intervention on the reproductive health  and response to treatment in infertile couples</public_title>
      <acronym></acronym>
      <scientific_title>Design, implementation, and evaluation of an electronic support intervention versus usual care on improving the reproductive health of couples undergoing infertility treatment and investigating the effect of this intervention on the response to treatment:a randomized clinical trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-11-01</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>100</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/73423</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Other design features: A single_ blind clinical trial,  with a parallel control group. The randomization process will be carried out using computer program resulting 100 participants with 50 assigned to the intervention group and 50 to the control group, Randomization description: The random allocation of couples is conducted using a block of four and by a computer randomization administered by a statistician. A table is generated   from this allocation and envelopes are prepared by an individual who is not involved in this research. These envelopes are numbered sequentially and contain either the intervention or control type. The thick envelopes, arranged in the specified order, are then placed in a box. The responsibility for admitting participants to the infertility section, which is not involved in the research, lies with someone else. Once participants provide their consent to participant in the study, the admission officer of the infertility center will open the envelope and allocate participant to the designated group. Participants will remain unaware of the group allocation, Blinding description: All participants (infertile couples) in the control and intervention groups will receive routine care, however the intervention group will also receive electronic counseling through educational videos posted on the infertility center website. These videos will have their educational content reviewed and approved by professors in this field. Participants in the control group will only receive usual care. Both groups will be unaware of this allocation. Clinical caregivers will perform all routine tasks for both groups without being notified. The person responsible for data collection is a research assistant who will complete the questionnaires over the phone or in person for both groups. The research assistant who analyzes the data from the questionnaires will also be unaware of the assigned groups.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Infertility.</hc_freetext>
      <i_freetext>Control group: usual care provided infertility ward.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
After publishing the article and anonymizing the participants, the data file can be sent via email as requested

When:
After publishing the research paper of the project for 6 months

To whom:
For all Academic Researcher

Conditions:
An approved proposal whose goals indicate the need for this information

Where to obtain:
By Email

How to obtain:
After the approval of the project partners, the information will be sent within three weeks

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Azam Hamidzadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>7th Tir square, Tehran street</address>
        <city>Shahroud</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3614773955</zip>
        <telephone>+98 23 3239 5054</telephone>
        <email>Azhamidzadeh@shmu.ac.ir</email>
        <affiliation>Shahroud University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Shahrbanoo Salehin</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>7th Tir square, Tehran street</address>
        <city>Shahroud</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3614773955</zip>
        <telephone>+98 23 3239 5054</telephone>
        <email>drbsalehin@gmail.com</email>
        <affiliation>Shahroud University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>A Diagnosis of infertility or a history of unsuccessful attempts to conceive for twelve months or more, primary or secondary infertility, absence of living children in secondary infertility, absence of adopted children, ability to read and write, residents of Shahroud city, couples receiving assisted reproductive methods For the first time, the agreement of both couples to participate in the study, having a smart phone or computer that receives the educational program or text messages and mastering its use at home, work, etc., having informed consent to participate in the study, lack of Any physical or mental illness in the couple, willing to participate in the research</inclusion_criteria>
      <agemin>21 years</agemin>
      <agemax>45 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Having psychological diseases, a history of psychological diseases, taking psychiatric drugs or participating in other psychological interventions during the treatment stages such as (IVF...), experiencing a stressful or unfortunate event in the last 6 months and engaging in smoking, alcohol or consumption, or drugs use in couples.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>Male and F</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>N97.4</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Control group: usual care provided infertility ward</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Improving Reproductive Health. Timepoint: Before intervention, after completion of counseling sessions. Method of measurement: Reproductive Health Questionnaire.</prim_outcome>
      <prim_outcome>Infertility stressB. Timepoint: Before the intervention - after the counseling sessions. Method of measurement: Using the Infertility Stress Questionnaire.</prim_outcome>
      <prim_outcome>Life Style. Timepoint: Before the intervention - after the counseling sessions. Method of measurement: Using the Walker's Health Promotion Lifestyle Questionnaire.</prim_outcome>
      <prim_outcome>The scores of the dimensions of the sexual self-concept. Timepoint: Before the intervention - after the counseling sessions. Method of measurement: Using the Snell Sexual Self-Concept Questionnaire.</prim_outcome>
      <prim_outcome>Drug Compliance (MARS's 10-item questionnaire) was conducted to measure drug compliance, the grading rate was never = 5, rarely = 4, sometimes = 3, most often = 2, always = 1. The scores obtained from this The questionnaire is divided into 10, and thus the range of scores to be obtained in a questionnaire is from 1 to 5. A score of more than 4.5 indicates good drug compliance and a score of less than 4.5 indicates poor drug compliance.). Timepoint: Before the intervention - after the counseling sessions. Method of measurement: Using questionnaire Medication Adherence (MARS).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Ovarian follicle size. Timepoint: Before the intervention and during 10th to 12th of menstrual cycle (in case of lack of proper size of the ultrasound follicle on days 14-16 and finally 20-22 cycles)  after the intervention. Method of measurement: vaginal ultrasound.</sec_outcome>
      <sec_outcome>Numbers of dominant follicles. Timepoint: Before the intervention and during 10th to 12th of menstrual cycle (in case of lack of proper size of the ultrasound follicle on days 14-16 and finally 20-22 cycles)  after the intervention. Method of measurement: vaginal ultrasound.</sec_outcome>
      <sec_outcome>Implantation Rate. Timepoint: Two weeks after the assisted reproductive procedure. Method of measurement: Serum BhCG level.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahroud University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-11-06</approval_date>
        <contact_name>Ethics committee of Shahroud University of Medical Sciences</contact_name>
        <contact_address>Shahroud University of Medical Sciences and Health Services, Hafte Tir Square, Taheri Ave Shahroud Semnan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
